K-numberK253406
Device nameS250-FIT Proton Beam Radiation Therapy Device (S250-FIT)
ApplicantMevion Medical Systems, Inc.
Product codeLHN
Device classClass II
Decision dateMar 25, 2026
DecisionSubstantially Equivalent
Regulation892.5050
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The MEVION S250-FIT is a proton beam radiation therapy system that delivers therapeutic proton radiation to patients with localized tumors and other radiation-susceptible conditions, particularly those above the mid-chest or carina when the patient is in a fully seated position. The device uses a 230 MeV superconducting synchrocyclotron with pencil beam scanning modality and includes an optional 2D oblique X-ray imaging subsystem for patient alignment verification.

Technological characteristics

The subject device is identical to its predicate in all core specifications: 230 MeV synchrocyclotron, 30-230 MeV usable energy, pencil beam scanning, 2 Gy/min dose rate, ±0.1 g/cm² spot range accuracy, and boron-carbide ceramic range shifter plates. The only difference is the addition of an optional 2D Oblique X-Ray imaging system for secondary patient positioning verification, which does not modify the primary treatment delivery method or allow deltas to the upright positioner.

Test standards cited

Testing followed IEC 60601-1 (medical electrical equipment safety), IEC 60601-1-2 (EMC), IEC 60601-2-68 (X-ray image-guided radiotherapy), IEC 60601-2-54 (X-ray equipment), IEC 60825-1 (laser safety), IEC 62304 (software development), ANSI/AAMI SW96:2023 (cybersecurity), IEC 62366-1 (human factors), and relevant FDA guidance documents on software, cybersecurity, and human factors.

Substantial equivalence argument

The subject device is substantially equivalent because both the subject and predicate devices have identical intended use, the same core technical specifications and beam delivery characteristics, and the optional 2D imaging subsystem does not raise new safety or effectiveness questions as it provides only secondary verification without affecting primary treatment delivery or clinical outcomes.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →